Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2006
12/05/2006US7144855 Protein complex from ion-exchange chromatography for treatment of bacterial infections
12/05/2006US7144738 Materials for enhancing staining of biopolymers in matrices
12/05/2006US7144731 monoclonal antibody immunoreactive with a stem cell factor; hybridoma cell line; can stimulate growth of primitive progenitors including early hematopoietic progenitor cells
12/05/2006US7144728 Method of inducing anergic T helper cells
12/05/2006US7144723 Model gram-positive bacteria which have sodium requirement for production, discovery and testing of immunomodulators, agrichemicals, enzyme inhibitors, viricides, bactericides, fungicides and anticarcinogenic agents; drug screening
12/05/2006US7144720 ADAM gene having a novel base sequence; an ADAM protein encoded by it has the protease activity and is involved in degradation of an extracellular matrix; recombinant vector comprising the DNA; recombinant host cell
12/05/2006US7144714 recombinantly coexpressing a Dicer protein with an R2D2 protein to form a complex; contacting complex with a double-stranded RNA wherein the complex cleaves the dsRNA into siRNA; Drosophila R2D2 protein; Drosophila Dicer-2 protein; may be coexpressed in insect cells using a baculovirus expression system
12/05/2006US7144711 Nucleotide sequences coding G protein coupled-receptor independent activators and inhibitors of the pheromone pathway for treating and preventing cell proliferative and atherosclerotic disorders
12/05/2006US7144709 Diagnostics based on tetrazolium compounds
12/05/2006US7144707 Determination of risk and treatment of complications of prematurity
12/05/2006US7144704 Incubating mammalian cell expressing multidrug resistance gene or P-glycoprotein with immunological reagent specific for a biochemical conformation; evaluating binding; drug screening for anticarcinogenic agents
12/05/2006US7144703 Composition
12/05/2006US7144702 Comprises conducting PCR using a member selected from the group consisting of two primers that hybridize under stringent conditions to a nucleic acid molecule having a common nucleotide sequence for all species in the target plant genus
12/05/2006US7144701 Screening numerous CpG dinucleotide rich fragments affixed on a screening array; positive hybridization signals indicate the presence of methylated sites.
12/05/2006US7144700 Removing photolabile group from nucleic acid, nucleotide, or nucleoside in presence of 9,10-dimethylanthrancene sensitizer; deblocking and deprotective removal of (( alpha -methyl-2-nitropiperonyl)-oxy)carbonyl (MeNPOC), ((Phenacyl)-oxy)carbonyl (PAOC), and O-(9-phenylxanthen-9-yl) (PIXYL) groups
12/05/2006US7144699 Iterative resequencing
12/05/2006US7144698 Postweaning multisystemic wasting syndrome virus from pigs
12/05/2006US7144697 Synthetic antigen for the detection of antibodies immunoreactive with HIV virus
12/05/2006US7144696 Use of azetidinone compounds
12/05/2006US7144616 Microfabricated elastomeric valve and pump systems
12/05/2006US7144496 Biological fluid analysis device
12/05/2006US7144119 System and method for programmable illumination pattern generation
12/05/2006CA2246802C A human cytomegalovirus combined antigen and its use
12/05/2006CA2215067C Use of betulinic acid and its derivatives for inhibiting malignant melanoma growth and a method of monitoring this
11/2006
11/30/2006WO2006128192A2 Use of free circulating dna for diagnosis, prognosis, and treatment of cancer
11/30/2006WO2006128138A2 Biodetection by nucleic acid-templated chemistry
11/30/2006WO2006128124A2 Total awareness surveillance system
11/30/2006WO2006128117A2 Polymorphisms in mitochondrial transcription factor a (tfam) gene and their associations with measures of marbling and subcutaneous fat dept in beef cattle
11/30/2006WO2006128116A2 Polymorphisms in fatty acid binding protein 4(fabp4) gene and their associations with measures of marbling and subcutaneous fat depth in beef cattle
11/30/2006WO2006128098A2 Cytometric system including nucleic acid sequence amplification, and method
11/30/2006WO2006128027A1 Functionally active recombinant peptides, methods for producing same and interactions with other peptides
11/30/2006WO2006128010A2 Quantification of nucleic acids and proteins using oligonucleotide mass tags
11/30/2006WO2006127913A2 Modulation of lmw-ptpase expression
11/30/2006WO2006127704A2 Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia
11/30/2006WO2006127609A2 Polymorphism in the macrophage migration inhibitory factor (mif) gene as marker for prostate cancer
11/30/2006WO2006127607A2 Pi3k pathway mutations in cancer
11/30/2006WO2006127562A2 Wireless power transmission system
11/30/2006WO2006127537A2 Thyroid fine needle aspiration molecular assay
11/30/2006WO2006127507A2 Compounds and methods for labeling oligonucleotides
11/30/2006WO2006127420A1 Methods for improving fidelity in a nucleic acid synthesis reaction
11/30/2006WO2006127294A2 Methods for diagnosis or prognosis of late age onset disease
11/30/2006WO2006127197A2 Mechanism to support transparent roaming in heterogeneous service discovery systems
11/30/2006WO2006127023A2 Epoxy enhanced polymer membrane to increase durability of biosensors
11/30/2006WO2006126865A1 Method for measuring effectively the activity of cytotoxic t lymphocyte in human and out-bred animals
11/30/2006WO2006126706A1 Prophylactic/therapeutic agent for psychotic disorder such as bipolar mood disorder and schizophrenia, screening method for the same, and method for determination of risk for the development of the disease
11/30/2006WO2006126618A1 Method of determining gene polymorphism for judgment of disease risk level, method of judging disease risk level and array for relevant judgment
11/30/2006WO2006126574A1 Method for induction of es cell differentiation
11/30/2006WO2006126570A1 Method for simultaneous analysis of multiple bioilogical reactions or changes in in vivo conditions
11/30/2006WO2006126040A1 Bacterial and bacterial associated mirnas and uses thereof
11/30/2006WO2006125855A1 Correction method and measurement device for anti-stokes photoluminescence measurement
11/30/2006WO2006125830A2 Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseases
11/30/2006WO2006125827A1 Serine proteases with altered sensitivity to activity-modulating substances
11/30/2006WO2006125808A1 Method for analysis of de-novo transcribed rna in vivo
11/30/2006WO2006125513A1 Genetic association of polymorphisms in the atf6-alpha gene with insulin resistance phenotypes
11/30/2006WO2006125493A2 USE OF NOVEL HNF4α TARGET GENES AND THEIR GENE PRODUCTS
11/30/2006WO2006125458A1 Parallel sequencing of transformed nucleic acids in encapsulated cells
11/30/2006WO2006125301A1 Diagnostic applications of microarrays in organ transplantation
11/30/2006WO2006125267A1 Isothermal strand displacement amplification using primers containing a non-regular base
11/30/2006WO2006117596A8 Nucleic acid probes and nucleic acid analog probes
11/30/2006WO2006109193A3 Selection of highly efficient antigen presenting cells for regulating immunity and uses thereof
11/30/2006WO2006102111A3 Biomarker for sensitivity to mtor inhibitor therapy in kidney cancer
11/30/2006WO2006096345A3 Coagulation and fibrinolytic cascades modulator
11/30/2006WO2006074878A3 Method and kit for detecting mycobacterium avium subsp. paratuberculosis (map) in samples of faeces, body tissues or milk
11/30/2006WO2006063717A3 Polymerase-independent analysis of the sequence of polynucleotides
11/30/2006WO2006058031A3 Microarray quality control
11/30/2006WO2006037485A3 Methods and kits for the prediction of therapeutic success and recurrence free survival in cancer therapy
11/30/2006WO2006014490A3 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same
11/30/2006WO2006007180A3 Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia
11/30/2006WO2005116256A3 Device for extracting biological molecules from tissue specimens
11/30/2006WO2005113811A3 Combinatorial selection of phosphorothioate aptamers for tgf-beta
11/30/2006WO2005100989A3 Hepatotoxicity molecular models
11/30/2006WO2005089287A3 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
11/30/2006WO2005040343A3 Improved apparatus and method for identification of biomolecules, in particular nucleic acid sequences, proteins, and antigens and antibodies
11/30/2006WO2004061124A3 Compositions, methods, and systems for inferring bovine breed
11/30/2006WO2004047728A3 Compositions and methods for the treatment of immune related diseases
11/30/2006WO2003016477A3 Insect or83b odorant receptor
11/30/2006US20060272056 Plant 1-deoxy-D-xylulose 5-phosphate synthase
11/30/2006US20060272042 designated J-101 and having representative seed deposited with American Type Culture Collection (ATCC) with Accession No. PTA-4814;
11/30/2006US20060272039 Methods of identifying longevity modulators and therapeutic methods of use thereof
11/30/2006US20060272035 Screening method with the use of TBK1 knockout mouse
11/30/2006US20060271309 Method of diagnosis of cancer based on gene expression profiles in cells
11/30/2006US20060270841 Assays to monitor amyloid precursor protein processing
11/30/2006US20060270840 Pentopyranosyl nucleic acid conjugates
11/30/2006US20060270699 Stabilization of hypoxia inducible factor (HIF) alpha
11/30/2006US20060270624 Gapped 2' modified oligonucleotides
11/30/2006US20060270623 RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)
11/30/2006US20060270619 Polynucleotide used in diagnosis of cell proliferative disease, and as target molecules for developing drugs
11/30/2006US20060270618 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
11/30/2006US20060270604 Pharmaceutical preparations of Fn3 polypeptides for human treatments
11/30/2006US20060270595 Nucleic acids encoding compositions of THAP-family chemokine binding domains
11/30/2006US20060270062 Mass spectrometric immunoassay
11/30/2006US20060270029 Automatable artificial immune system (AIS)
11/30/2006US20060270025 Microfermentor device and cell based screening
11/30/2006US20060270019 Method for producing lactic acid bacterium culture containing bacteriocin and a method for preserving food products for by using it
11/30/2006US20060270010 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
11/30/2006US20060269984 Method for identifying Listeria monocytogenes and culture medium
11/30/2006US20060269982 Colorimetric method for detecting bacterial or fungal pathogens by detecting peptidoglycan or (1-3)- beta -D-glucan; incubating sample with hemolymph from a Lepidopteran insect, a phenoloxidase substrate that generates a reaction product, and 3-methyl-2-benzothiazolinone hydrazone then detecting color
11/30/2006US20060269981 Diagnostic kit for hirschsprung disease (Congenital Megacolon)
11/30/2006US20060269980 Complete chemical and enzymatic treatment of phosphorylated and glycosylated proteins on protein chip arrays
11/30/2006US20060269979 High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases